Evidence map›Paper›PMID 41865046›Full record

ArticleScientific reports2026

Microfluidic process-property correlations of dsRNA lipid nanoparticle formulations.

Pascal Geisler, Eileen Knorr, Frank Steiniger, Artem Levin, Christoph Hartwig, Till F Schäberle, Andreas Vilcinskas, Christoph Hellmann

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Design of Lipopeptides and dsRNA-Lipopeptide Complexes for Sprayable RNAi-Based Plant Protection.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pascal GeislerFraunhofer Institute for Molecular Biology and Applied Ecology IME, 35392, Giessen, Germany.
Eileen KnorrFraunhofer Institute for Molecular Biology and Applied Ecology IME, 35392, Giessen, Germany.
Frank SteinigerElectron Microscopy Center, Jena University Hospital, Friedrich Schiller University, 07743, Jena, Germany.
Artem LevinMalvern Panalytical GmbH, 34123, Kassel, Germany.
Christoph HartwigFraunhofer Institute for Molecular Biology and Applied Ecology IME, 35392, Giessen, Germany.
Till F SchäberleFraunhofer Institute for Molecular Biology and Applied Ecology IME, 35392, Giessen, Germany.
Andreas VilcinskasFraunhofer Institute for Molecular Biology and Applied Ecology IME, 35392, Giessen, Germany.
Christoph HellmannFraunhofer Institute for Molecular Biology and Applied Ecology IME, 35392, Giessen, Germany. christoph.hellmann@ime.fraunhofer.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The control of agricultural pest insects currently relies on broad-spectrum insecticides, which select for resistance in pest populations while also harming non-target species. In contrast, RNA interference (RNAi) has a species-dependent mode of action based on the delivery of double-stranded RNA (dsRNA) that precisely matches essential genes in pests, minimizing off-target effects. The successful application of RNAi requires the development of sprayable formulations that temporarily protect the dsRNA from environmental degradation (allowing uptake by pest insects) but also ensure the efficient release of the dsRNA within insect cells. Lipid nanoparticles (LNPs) based on pharmaceutical-grade lipids are currently too expensive for agricultural use, making the development of affordable and scalable dsRNA-LNP formulations essential for spray-induced gene silencing. Here we used technical-grade lipid components (available at the ton scale) and demonstrated the cost-effective production of structurally controlled dsRNA-LNP formulations by optimizing formulation recipes and scaling up the microfluidic mixing process. The dispersions contained spherical nanoparticles less than 100 nm in diameter, with a zeta potential exceeding + 20 mV, and an entropy-driven Gibbs free energy change for dsRNA-LNP decomplexation in the moderate range of approximately – 20 kJ/mol. The formulations protected dsRNA from RNase III degradation and hydrolysis at pH 4–11 for at least 24 h while allowing SDS-mediated dsRNA release. Our work provides insight into the structure–property correlations of inexpensive dsRNA-LNP formulations for sustainable RNAi-based pest management systems.

Indexed as

LipidsMicrofluidicsNanoparticlesRNA, Double-StrandedAnimalsLiposomesRNA InterferenceLipid NanoparticlesLipidsLiposomesRNA, Double-StrandedCryogenic electron microscopydsRNA formulationFormulation stabilityIsothermal titration calorimetryLipid nanoparticlesMicrofluidic mixingPest insect controlRNA interference

Identifiers

PMID41865046
PMCPMC13009477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.